Absci Corporation Common Stock vs. bioAffinity Technologies, Inc. Common Stock
ABSI
Absci Corporation Common Stock
$8.80 -0.45%
VS BIAFbioAffinity Technologies, Inc. Common Stock
$10.45 +58.60%
bioAffinity Technologies, Inc. Common Stock (BIAF) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABSI | BIAF | |
|---|---|---|
| Market Cap | $1.52 billion | $3.90 million |
| Revenue (TTM) | $1.56 million | $5.90 million |
| Net Income (TTM) | $-121,077,000 | $-15,185,242 |
BIAF leads on 2 of 3 size & scale factors.
Valuation
| ABSI | BIAF | |
|---|---|---|
| Price / Book | 6.16 | 1.04 |
| Price / Sales | 971.86 | 0.66 |
BIAF leads on 2 of 2 valuation factors.
Profitability
| ABSI | BIAF | |
|---|---|---|
| Net Margin | -7756.37% | -257.33% |
| Return on Equity | -49.19% | -402.92% |
ABSI and BIAF split the profitability factors evenly.
Risk & Sentiment
| ABSI | BIAF | |
|---|---|---|
| Short Interest | 0.12% | 1.46% |
ABSI leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABSI overview, ABSI financials, BIAF overview, BIAF financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.